Company intelligence

NeuroSpectrum Insights

BiotechActive
We're still building this profile — here is what Pulse has covered.

Recent changes

  1. Jul 10, 2026NeuroSpectrum Insights Amends IPO Filing a Fifth Time Pulse story

Latest Pulse

  1. NeuroSpectrum Insights Amends IPO Filing a Fifth TimeNeuroSpectrum Insights, formerly Autism Diagnostic Technologies, filed its fifth S-1/A amendment since January, the latest step in a lengthy SEC review process for its planned public offering.→

Coverage Timeline

newest first
  1. IPONeuroSpectrum Insights Amends IPO Filing a Fifth Time→

All Coverage

IPO

NeuroSpectrum Insights Amends IPO Filing a Fifth Time

Related Companies

Same sector
Attovia TherapeuticsApnimedBraveheart BioLatigo BiotherapeuticsScribe Therapeutics